Long-term insurance for breast cancer survivors.
出版信息
Johns Hopkins Med Lett Health After 50. 2004 Apr;16(2):3, 7.
PMID:15088564
Abstract
摘要
相似文献
1
Long-term insurance for breast cancer survivors.
Johns Hopkins Med Lett Health After 50. 2004 Apr;16(2):3, 7.
2
Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett. 2004 Mar;22(3):4.
3
Breast cancer drug shows promise for some survivors.
Rep Med Guidel Outcomes Res. 2003 Oct 31;14(21):7-9.
4
New breast cancer drug.
US News World Rep. 2001 Dec 24;131(26):52.
5
Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer.
Expert Rev Anticancer Ther. 2008 Dec;8(12):1871-81. doi: 10.1586/14737140.8.12.1871.
6
The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Womens Health Issues. 2004 Jan-Feb;14(1):7-10. doi: 10.1016/j.whi.2003.12.006.
7
New treatment boosts outlook for breast cancer survivors.
Mayo Clin Womens Healthsource. 2004 Mar;8(3):3.
8
[Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
Magy Onkol. 2008 Jun;52(2):225-6. doi: 10.1556/MOnkol.52.2008.2.11.
9
Anastrozole for breast cancer: recent advances and ongoing challenges.
Expert Rev Anticancer Ther. 2006 Jun;6(6):839-48. doi: 10.1586/14737140.6.6.839.
10
Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
Oncology (Williston Park). 2005 Mar;19(3):277, 360.
Zotero 插件